Prev：Engineered outer membrane vesicles enhance solid tumour CAR-T cell therapy(BMD0073-26.6)
Next：Engineering ferroptosis radiosensitizer for SPARC-targeted degradation: A strategy to reverse radioresistant non-small cell lung cancer(KTA0005-12.9)
